Cyclic changes in the vaginal epithelium of normal rhesus macaques

Journal of Endocrinology

Volumn 190, Issue 3, 2006, Pages 829-835

  Poonia, B ^a   Walter, L ^a   Dufour, J ^a   Harrison, R ^a   Marx, P A ^a   Veazey, R S ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; FEMALE; FOLLICULAR PHASE; HUMAN IMMUNODEFICIENCY VIRUS 1; KERATINIZATION; MACACA; MATURATION; MENSTRUAL CYCLE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEXUALLY TRANSMITTED DISEASE; VAGINA EPITHELIUM; VAGINA MUCOSA; VIRUS TRANSMISSION;

AGING; ANIMALS; EPITHELIUM; ESTRADIOL; FEMALE; HIV INFECTIONS; MACACA MULATTA; MENSTRUAL CYCLE; MODELS, ANIMAL; PROGESTERONE; RADIOIMMUNOASSAY; VAGINA;

EID: 33749864595     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06873     Document Type: Article

References (18)

1. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, Nalugoda F, Kiddugavu M, Sewankambo N, Quinn TC et al. 2005 Indeased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 366 1182-1188.
2. Lederman MM, Veazey RS, Oford R, Mosier DE, Dufour J, Mefford M, Piatak M Jr., Lifson JD, Salkowitz JR, Rodriguez B et al. 2004 Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306 485-487.
3. Ma Z, Lu FX, Torten M & Miller CJ 2001 The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clinical Immunology 100 240-249.
4. Mainini G, Scaffa C, Rotondi M, Messalli EM, Quirino L & Ragucci A 2005 Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose l7beta-estradiol vaginal tablets. Clinical and Experimental Obstetrics and Gynecology 32 111-113.
5. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamschikov GV, Chen D & Eldridge JH 1993 Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260 1323-1327.
6. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, Miller CJ, Claypool LE, Ho DD et aL 1996 Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Medicine 2 1084-1089.
7. Miller CJ, Alexander NJ, Sutjipto S, Lackner AA, Gettie A, Hendrickx AG, Lowenstine LJ, Jennings M & Marx PA 1989 Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. Journal of Virology 63 4277-4284.
8. Miller CJ, Alexander NJ, Vogel P, Anderson J & Marx PA 1992 Mechanism of genital transmission of SIV:. a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. Journal of Medical Primatology 21 64-68.
9. Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, Lee K, Grohskopf LA, Monsour M, Butera S & Folks TM 2005 Multiple vaginal exposures to low doses of R5 simim-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. Journal of Infectious Diseases 191 164-173.
10. Quinn TC & Overbaugh J 2005 HIV/AIDS in women: an expanding epidemic. Science 308 1582-1583.
11. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo, T & Gray RH 2000 Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine 342 921-929.
12. Regoes RR, Longini IM, Feinberg MB & Staprans SI 2005 Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. PLoS Medicine 2 e249.
13. Shattock RJ & Moore JP 2003 Inhibiting sexual transmission of HIV-1 infection. Nature Reviews Microbiology 1 25-34.
14. Sjoberg I, Cajander S & Rylander E 1988 Morphometric characteristics of the vaginal epithelium during the menstrual cycle. Gynecologic and Obstetric Investigation 26 136-144.
15. Smith SM, Mefford M, Sodora D, Elase Z, Singh M, Alexander N, Hess D & Marx PA 2004 Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. Acquired Immune Defidency Syndrome 18 1637-1643.
16. Sodora DL, Gettie A, Miller CJ & Marx PA 1998 Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Researrh and Human Retroviruses 1 S119-S123.
17. Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klaase PJ, Burton DR et al. 2003a Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV gp120. Nature Medicine 9 343-346.
18. Veazey RS, Klasse PJ, Ketas TJ, Reeves JD, Piatak M, Jr., Kunstman K, Kuhmarm SE, Marx PA, Lifson JD, Dufour J et al. 2003b Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. Journal of Experimental Medicine 198 1551-1562.